CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-12.38%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$459M
Cap. Flow
% of AUM
-3.78%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
868
New
52
Increased
314
Reduced
272
Closed
83
Top Buys
| 1 |
Procter & Gamble
PG
|
$37.1M |
| 2 |
Verizon
VZ
|
$26M |
| 3 |
Apple
AAPL
|
$25M |
| 4 |
Salesforce
CRM
|
$24.3M |
| 5 |
PepsiCo
PEP
|
$23.9M |
Top Sells
| 1 |
Waste Management
WM
|
$63.3M |
| 2 |
Microsoft
MSFT
|
$62.1M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
$55.6M |
| 4 |
Citigroup
C
|
$51.9M |
| 5 |
Johnson & Johnson
JNJ
|
$40.8M |
Sector Composition
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMW
201
DELISTED
VMware, Inc
VMW
| $11.7M | 0.1% |
102,723
-277,935
| -73% | -$31.7M |
|
202
Comcast
CMCSA
$125B
| $11.6M | 0.1% |
296,518
-473,404
| -61% | -$18.6M |
|
|
CCMP
203
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $11.6M | 0.1% |
66,464
+21,062
| +46% | +$3.68M |
|
204
KeyCorp
KEY
$20.8B
| $11.6M | 0.1% |
670,629
+219,683
| +49% | +$3.78M |
|
205
Charles River Laboratories
CRL
$8.07B
| $11.5M | 0.09% |
53,807
-13,723
| -20% | -$2.94M |
|
206
Dollar General
DG
$24.1B
| $11.5M | 0.09% |
46,762
+808
| +2% | +$198K |
|
207
HP
HPQ
$27.4B
| $11.3M | 0.09% |
344,522
-25,346
| -7% | -$831K |
|
208
Cogent Biosciences
COGT
$1.82B
| $11.3M | 0.09% |
1,250,889
-502,091
| -29% | -$4.53M |
|
|
KRTX
209
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $11.2M | 0.09% |
88,727
+26,632
| +43% | +$3.37M |
|
210
Insulet
PODD
$24.5B
| $11.1M | 0.09% |
51,125
+40,977
| +404% | +$8.93M |
|
211
MetLife
MET
$52.9B
| $11.1M | 0.09% |
176,162
+115,977
| +193% | +$7.28M |
|
212
Thomson Reuters
TRI
$78.7B
| $11.1M | 0.09% |
102,407
-31,197
| -23% | -$3.37M |
|
213
Credicorp
BAP
$20.7B
| $11M | 0.09% |
91,560
-126,040
| -58% | -$15.1M |
|
214
Revolution Medicines
RVMD
$7.57B
| $10.8M | 0.09% |
555,255
+121,051
| +28% | +$2.36M |
|
215
Nurix Therapeutics
NRIX
$758M
| $10.6M | 0.09% |
839,375
+74,269
| +10% | +$941K |
|
|
CERE
216
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $10.5M | 0.09% |
397,221
+145,603
| +58% | +$3.85M |
|
217
Ameresco
AMRC
$1.37B
| $10.5M | 0.09% |
230,288
| – | – |
|
218
KLA
KLAC
$119B
| $10.4M | 0.09% |
32,602
-18,082
| -36% | -$5.77M |
|
219
Wells Fargo
WFC
$253B
| $10.4M | 0.09% |
265,445
-8,491
| -3% | -$333K |
|
220
Union Pacific
UNP
$131B
| $10.3M | 0.08% |
48,116
+972
| +2% | +$207K |
|
221
Labcorp
LH
$23.2B
| $10.2M | 0.08% |
50,712
-21,251
| -30% | -$4.28M |
|
222
AT&T
T
$212B
| $10.2M | 0.08% |
486,233
-144,787
| -23% | -$3.03M |
|
223
United Rentals
URI
$62.7B
| $10M | 0.08% |
41,226
+20,157
| +96% | +$4.9M |
|
224
Keros Therapeutics
KROS
$633M
| $10M | 0.08% |
361,789
-58,881
| -14% | -$1.63M |
|
225
Arthur J. Gallagher & Co
AJG
$76.7B
| $9.93M | 0.08% |
60,889
+49,705
| +444% | +$8.1M |
|